Economy
Congo Ebola Vaccine Trial Begins With Three Shots in Sight
A pivotal trial of vaccines against the strain of Ebola that’s driving a deadly outbreak across parts of Africa has begun in the Democratic Republic of Congo, where the epidemic originated and the vast majority of cases and deaths has occurred.
Publication and source
PublicationSanalda Haber
SourceBloomberg
Published
CategoryEconomy
Summary from the source publisher’s news feed.